Most lately, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in similar spots as classical opioid receptors, it binds into a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts as a scavenger https://samuelx319zbc0.blog2freedom.com/profile